The Journal of Pediatrics
Volume 150, Issue 2 , Pages 134-139.e1, February 2007

Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience

Department of Pediatrics, Section of Nephrology, Columbus Children’s Hospital, The Ohio State University College of Medicine, Columbus, Ohio; Cardiovascular Clinical Research, AstraZeneca LP, Wilmington, DE; the Department of Pediatric Nephrology, University of Texas-Houston Medical School, Houston, TX; and Medicine and Pediatrics, Thomas Jefferson University Medical School, Philadelphia, PA.

Received 2 June 2006; received in revised form 24 July 2006; accepted 18 September 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 AstraZeneca LP provided support for this study.Toprol-XL and Seloken ZOK are registered trademarks of the AstraZeneca group of ompanies.Clinicaltrials.gov Identifiers: NCT00255502 and NCT00255528.

PII: S0022-3476(06)00922-X

doi:10.1016/j.jpeds.2006.09.034

Refers to article:

  • Is There a Role for β-Adrenergic Blockers in Treating Hypertension in Children?

    Russell W. Chesney, Deborah P. Jones
    The Journal of Pediatrics February 2007 (Vol. 150, Issue 2, Pages 121-122)

The Journal of Pediatrics
Volume 150, Issue 2 , Pages 134-139.e1, February 2007

Article Tools

* Image Usage & Resolution